Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Somerset Therapeutics LLC recalls Cisatracurium Besylate Injection USP

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Subpotent product:out of specification assay results observed during long term stability testing.
Products
  • Cisatracurium Besylate Injection USP
Where it was sold

Nationwide in the USA

Nationwide

Units affected
71,310 10mL vials
About this recall
Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01.